AcquisitionOther
Akoya Biosciences, Inc. acquired target
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Akoya Biosciences, Inc. -> target · $20 million
Masoud Toloue, PhD, Chief Executive Officer of Quanterix, said, "The strategic merits of the transaction remain strong even as the market has been focused on academic funding and tariff concerns.
Open source record (SEC) ↗